Case Report
Accepted on 10 Feb 2025
Case report: Complete response to four cycles of camrelizumab in a PD-L1 negative patient with advanced oral squamous cancer
in Cancer Immunity and Immunotherapy
Case Report
Accepted on 10 Feb 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 10 Feb 2025
in Endovascular and Interventional Neurology
Review
Accepted on 10 Feb 2025
in Cell Growth and Division
Original Research
Accepted on 10 Feb 2025
in Coronary Artery Disease
Original Research
Accepted on 10 Feb 2025
in Non-Neuronal Cells
Systematic Review
Accepted on 10 Feb 2025
in Alzheimer's Disease and Related Dementias
Original Research
Accepted on 10 Feb 2025
in Cellular Neurophysiology
Review
Accepted on 10 Feb 2025
in Non-Neuronal Cells
Perspective
Accepted on 10 Feb 2025
in Drugs Outcomes Research and Policies
Systematic Review
Accepted on 10 Feb 2025
in Drugs Outcomes Research and Policies
Original Research
Accepted on 10 Feb 2025
in Cornea and Refractive Surgery
Original Research
Accepted on 10 Feb 2025
in Sustainable and Intelligent Phytoprotection
Original Research
Accepted on 10 Feb 2025
in Thoracic Oncology
Systematic Review
Accepted on 10 Feb 2025
in Heart Failure and Transplantation
Original Research
Accepted on 10 Feb 2025
in Cancer Genetics and Oncogenomics
Review
Accepted on 10 Feb 2025
in Molecular Diagnostics and Therapeutics